You can't correct for inadequate sample sizes with statistics and still expect a clinically relevant result (the confidence interval would be too large). The is

You can't correct for inadequate sample sizes with statistics and still expect a clinically relevant result (the confidence interval would be too large). The issue isn't contamination in small samples, it's that the biomarkers they need to measure may not be accurately measurable at such small volumes - in particular with the value ranges required for the test. It may just be that their "nanotainer" tests may only be viable for boolean tests like their herpes test (herpes DNA present - yes / no).